Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18887693 | 0.86 | LMNA (0.46) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL22013849 | 0.78 | USP2 (0.48) | LMNACYP2D6MEN1KMT2AMAPT | |
| SCHEMBL24494612 | 0.75 | LMNA (0.46) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL19944717 | 0.75 | LMNA (0.43) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL16152341 | 0.75 | — | — | |
| SCHEMBL22435464 | 0.74 | LMNA (0.47) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL267463 | 0.73 | LMNA (0.68) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL6351413 | 0.73 | MAPT (0.57) | LMNACYP2D6ADRB2ADRB1ADRB3 | |
| SCHEMBL24554358 | 0.73 | ELANE (0.34) | KMT2AL3MBTL1MAPTTSHR | |
| SCHEMBL25952933 | 0.73 | CYP2D6 (0.43) | LMNACYP2D6ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10189847-B2 | Oxime ester compound and photopolymerization initiator containing said compound | ADEKA CORPORATION (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20170166575-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND | ADEKA CORPORATION (JP) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166575-A1 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND | RB1, PRMT9, KDM2B | LMNA 2393/4885CYP2D6 902/4885ADRB2 3286/4885 |
| US-10189847-B2 | Oxime ester compound and photopolymerization initiator containing said compound | PPOX, CCNO, MRTO4 | LMNA 2693/4885CYP2D6 976/4885ADRB2 3361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.